XiFin reports robust 2025 performance and strengthens AI and interoperability initiatives
XiFin reported strong operational growth across key segments in 2025, including 16.4% growth in its molecular diagnostics segment and 13.3% growth in its hospital segment. Volume flowing through XiFin Empower RCM increased 21.1%, reflecting accelerating adoption of the company’s next-generation AI-powered revenue cycle solution. Building on this momentum, XiFin also announced the appointment of Sanjay Kumar as Chief Technology Officer to advance its AI innovation strategy in 2026.
Kumar brings more than two decades of experience scaling cloud-native and AI-driven platform modernization initiatives across healthcare and technology organizations. His expertise will be instrumental as XiFin rolls out advanced AI capabilities to support growth in emerging areas such as Medical Devices and Durable Medical Equipment (DME).
Most recently, as CTO of ResMed’s $800M Residential Care Software business, including MatrixCare, Brightree, and MEDIFOX DAN, Kumar led a multi-year transformation that unified fragmented product portfolios into a single cloud-native platform, embedded machine learning and generative AI into clinical and revenue cycle workflows, and drove institutionalized AI-assisted software development, resulting in sustained double-digit growth. His experience and expertise position XiFin to further enhance and scale the capabilities of the XiFin Empower ecosystem.
As reimbursement models and interoperability policies continue to evolve, XiFin has also joined the Pharmacy Interoperability and Clinical Services Alliance (PICSA), sharing insights and expertise while reinforcing its commitment to advancing interoperability standards and supporting pharmacists as clinical care providers.
Through PICSA and broader industry collaboration, XiFin is helping shape national, state, and industry frameworks that improve access to clinical services, strengthen data exchange, and enable diagnostics providers and pharmacies to play a more integrated role in patient care delivery.
XiFin also added Jeff Margolis to its Board of Directors, a veteran healthcare IT executive with more than 35 years of leadership experience. Margolis previously served as CEO of multiple healthcare technology companies, including founding TriZetto, the industry’s first vertical SaaS platform, and currently serves as a Senior Advisor to Blackstone while supporting strategic investments and innovation across healthcare and information technology.
